Your browser doesn't support javascript.
loading
Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy.
Yegya-Raman, Nikhil; Wright, Christopher M; LaRiviere, Michael J; Baron, Jonathan A; Lee, Daniel Y; Landsburg, Daniel J; Svoboda, Jakub; Nasta, Sunita D; Gerson, James N; Barta, Stefan K; Chong, Elise A; Schuster, Stephen J; Maity, Amit; Facciabene, Andrea; Paydar, Ima; Plastaras, John P.
Afiliação
  • Yegya-Raman N; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Wright CM; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • LaRiviere MJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Baron JA; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Lee DY; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Landsburg DJ; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Svoboda J; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Nasta SD; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Gerson JN; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Barta SK; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Chong EA; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Schuster SJ; Department of Medicine, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, United States.
  • Maity A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Facciabene A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Paydar I; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
  • Plastaras JP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, United States.
Clin Transl Radiat Oncol ; 39: 100587, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36718252
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos